Visszatérés

Szolgáltatásink az alábbi országokban elérhetőek

Corporate

Európa:

Zászló Albánia Albánia Zászló Bosznia Herzegovina Bosznia Herzegovina Zászló Bulgária Bulgária Zászló Horvátország Horvátország Zászló Ciprus Ciprus Zászló Montenegró Montenegró Zászló Cseh Köztársaság Cseh Köztársaság Zászló Dánia Dánia Zászló Észtország Észtország Zászló Spanyolország Spanyolország Zászló Koszovó Koszovó Zászló Litvánia Litvánia Zászló Lettország Lettország Zászló Luxemburg Luxemburg Zászló Macedónia Macedónia Zászló Németország Németország Zászló Lengyelország  Lengyelország  Zászló Portugália Portugália Zászló Románia Románia Zászló Szerbia Szerbia Zászló Szlovákia Szlovákia Zászló Szlovénia Szlovénia Zászló Svájc Svájc Zászló Svédország Svédország Zászló Törökország Törökország Zászló Magyarország Magyarország Zászló Egyesült Királyság Egyesült Királyság Zászló Olaszország Olaszország

Ázsia:

Zászló UAE UAE Zászló Hong-Kong Hong-Kong Zászló Kuvait Kuvait Zászló Libanon Libanon

Afrika:

Zászló Dél-Afrika Dél-Afrika
Visszahívást kérek

Szeretne többet megtudni szolgáltasainkról?

Töltse ki az alábbi regisztrációs felületet és kollégáink hamarosan felveszik önnel a kapcsolatot, hogy válaszoljanak minden felmerülő kérdésére

    "Adatait semmilyen körülmények között nem tesszük harmadik fél számára hozzáférhetővé.

    Obraz

    Életmentő
    transzplantációk listája

    A Famicord csoport laboratóriumaiból kezelésre kiadott minták listája.

    Obraz
    Lp. Őssejt forrás Forrás típusa Diagnózis Érintett szakterület Kezelés éve Terápia Ország Páciens életkora
    1901 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Spain 67
    1902 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis Hematology 2024 Standard Therapy United Kingdom 48
    1903 Apheresis Allogeneic Non-Hodgkin’s lymphoma Hematology 2024 Standard Therapy NETHERLANDS 61
    1904 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 29
    1905 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 62
    1906 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Israel 63
    1907 Apheresis Allogeneic ETP-Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Poland 35
    1908 Apheresis Allogeneic Hodgkin lymphoma Hematology 2024 Standard Therapy Poland 4
    1909 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 23
    1910 Apheresis Allogeneic Fanconi Anemia Hematology 2024 Standard Therapy USA 27
    1911 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 69
    1912 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 44
    1913 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 49
    1914 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 20
    1915 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 50
    1916 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 74
    1917 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Austria 49
    1918 Apheresis Allogeneic Post-PV Myelofibrose Hematology 2024 Standard Therapy Germany 59
    1919 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 66
    1920 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 58
    1921 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 55
    1922 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy France 70
    1923 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy France 54
    1924 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 68
    1925 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Poland 41
    1926 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy USA 31
    1927 Apheresis Allogeneic Other leukemia Hematology 2024 Standard Therapy Italy 31
    1928 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Sweden 42
    1929 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 43
    1930 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 52
    1931 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 64
    1932 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 60
    1933 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 70
    1934 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
    1935 Apheresis Allogeneic Primary myelofibrosis Hematology 2024 Standard Therapy Germany 55
    1936 Apheresis Autologous Amyloid Light-Chain Amyloidosis Hematology 2024 Standard Therapy Germany 55
    1937 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 61
    1938 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
    1939 Apheresis Autologous Epstein–Barr Virus Positive Diffuse Large B-Cell Lymphoma Hematology 2024 Standard Therapy Germany 63
    1940 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 69
    1941 Apheresis Autologous Angioimmunoblastic T-cell lymphoma Hematology 2024 Standard Therapy Germany 58
    1942 Apheresis Allogeneic Acute lymphoblastic leukemia Hematology 2024 Standard Therapy Germany 19
    1943 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 66
    1944 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 61
    1945 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Canada 16
    1946 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 61
    1947 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 75
    1948 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2024 Standard Therapy USA 62
    1949 Apheresis Allogeneic Myelodysplastic Disorders Hematology 2024 Standard Therapy France 66
    1950 Apheresis Allogeneic B-Cell Lymphoma Hematology 2024 Standard Therapy Canada 70
    1951 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 60
    1952 Apheresis Allogeneic Myeloma Multiplex Hematology 2024 Standard Therapy Poland 57
    1953 Apheresis Allogeneic Diffuse large B-cell lymphoma Hematology 2024 Standard Therapy Poland 17
    1954 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 48
    1955 Apheresis Allogeneic Chronic lymphocytic leukemia Hematology 2024 Standard Therapy Germany 63
    1956 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 65
    1957 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 64
    1958 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 76
    1959 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 44
    1960 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 62
    1961 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy NETHERLANDS 25
    1962 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy USA 42
    1963 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy CROATIA 66
    1964 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 70
    1965 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2024 Standard Therapy Switzerland 68
    1966 Apheresis Allogeneic Chronic Myelomonocytic Leukaemia Hematology 2024 Standard Therapy NETHERLANDS 62
    1967 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2024 Standard Therapy USA 58
    1968 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 62
    1969 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Belarus 54
    1970 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Spain 9
    1971 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 66
    1972 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 67
    1973 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 54
    1974 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy South Africa 54
    1975 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 60
    1976 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Sweden 60
    1977 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Spain 67
    1978 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Germany 66
    1979 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 53
    1980 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 65
    1981 Apheresis Autologous Non-Hodgkin Lymphoma, rezidiv Hematology 2024 Standard Therapy Germany 64
    1982 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 57
    1983 Apheresis Allogeneic Acute myeloid leukemia Hematology 2024 Standard Therapy Germany 66
    1984 Apheresis Allogeneic Acute lymphoblastic leukemia Hematology 2024 Standard Therapy Germany 50
    1985 Apheresis Autologous Multiple myeloma Hematology 2024 Standard Therapy Germany 57
    1986 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 70
    1987 Apheresis Allogeneic Multiple Organ Dysfunction Syndrome Hematology 2024 Standard Therapy Germany 42
    1988 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 32
    1989 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 76
    1990 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2024 Standard Therapy Italy 63
    1991 Apheresis Allogeneic Early T-cell precursor Acute Lymphoblastic Leukemia Hematology 2024 Standard Therapy Australia 43
    1992 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy USA 72
    1993 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2024 Standard Therapy Germany 72
    1994 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Poland 52
    1995 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy USA 73
    1996 Apheresis Allogeneic Myelofibrosis Hematology 2024 Standard Therapy Poland 68
    1997 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Italy 63
    1998 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy Czechia 46
    1999 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2024 Standard Therapy France 64
    2000 Apheresis Allogeneic Primary Immunodeficiencies Hematology 2024 Standard Therapy Russia 7